Results
eNauka >
Rezultati >
Subcutaneous infliximab (CT-P13 SC) as maintenance therapy for Crohn's disease and ulcerative colitis: 2-year results from open-label extensions of two randomized controlled trials (LIBERTY)
| Naziv: | Subcutaneous infliximab (CT-P13 SC) as maintenance therapy for Crohn's disease and ulcerative colitis: 2-year results from open-label extensions of two randomized controlled trials (LIBERTY) | Autori  : | Colombel, Jean Frederic; ...; Sreckovic, Slobodan; ...; (broj, koautora 33) | Godina: | 2025 | Publikacija: | JOURNAL OF CROHNS & COLITIS | ISSN: | 1873-9946 Journal of Crohn#s and Colitis Pretraži identifikator |
Tip rezultata: | Naučni članak | Kolacija: | vol. 19 br. 6 | DOI: | 10.1093/ecco-jcc/jjaf060 | WoS-ID: | 001501381900001 | Scopus-ID: | 2-s2.0-105008338734 | PMID: | 40243842 | PMCID: | PMC12134888 | URI: | https://enauka.gov.rs/handle/123456789/984910 | Projekat: | Celltrion, Inc Celltrion, Inc. (Incheon, Republic of Korea) |
Izvor metapodataka: | (Preuzeto iz Nasi u WoS) | M-kategorija: | 21aM21a - Vodeći međunarodni časopis kategorije M21a |
Items in eNauka are protected by copyright, with all rights reserved, unless otherwise indicated.